Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-((1-pyrrolidinylcarbonyl)methyl)-4-(3,4,5-trimethoxycinnamoyl)piperazine
2. 1-((1-pyrrolidynylcarbonyl)methyl)-4-(3,4,5-trimethoxycinnamoyl)piperazine Maleate
3. 67350-md
4. Cinepazide
5. Md-67350 Free Base
6. Vasodistal
1. 26328-04-1
2. Vasodistal
3. Brendil
4. Cinepazide Maleate [jan]
5. Cinepazide (maleate)
6. 28044-44-2
7. Md 67350
8. Y35b3va60v
9. 26328-04-1 (maleate)
10. Nsc-291562
11. Md-67350
12. Cinepazide Maleate (jan)
13. 1-((1-pyrrolidinylcarbonyl)methyl)-4-(3,4,5-trimethoxycinnamoyl)piperazine Maleate
14. 1-((pyrrolidin-1-ylcarbonyl)methyl)-4-(3,4,5-trimethoxycinnamoyl)piperazine Maleate
15. 1-[(1-pyrrolidinylcarbonyl)methyl]-4-(3,4,5-trimethoxycinnamoyl)piperazine Maleate
16. 1-[(pyrrolidin-1-ylcarbonyl)methyl]-4-(3,4,5-trimethoxycinnamoyl)piperazine Maleate
17. 1-(2-oxo-2-(1-pyrrolidinyl)ethyl)-4-(1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl)piperazine (z)-2-butenedioate (1:1)
18. Maleate De Cinepazide
19. Mls003115636
20. Unii-y35b3va60v
21. Maleate De Cinepazide [french]
22. 2-propen-1-one, 1-(4-(2-oxo-2-(1-pyrrolidinyl)ethyl)-1-piperazinyl)-3-(3,4,5-trimethoxyphenyl)-, (2z)-2-butenedioate (1:1)
23. 2-propen-1-one, 1-[4-[2-oxo-2-(1-pyrrolidinyl)ethyl]-1-piperazinyl]-3-(3,4,5-trimethoxyphenyl)-, (2z)-2-butenedioate (1:1)
24. Einecs 247-613-1
25. Einecs 248-795-5
26. Nsc 291562
27. (e)-1-(4-(2-oxo-2-(pyrrolidin-1-yl)ethyl)piperazin-1-yl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one Maleate
28. Schembl1062368
29. Cinepazide Maleate [mi]
30. Chembl4303265
31. Piperazine, 1-[(1-pyrrolidinylcarbonyl)methyl]-4-(3,4,5-trimethoxycinnamoyl)-, Maleate
32. Hms3885g05
33. Cinepazide Maleate [mart.]
34. (z)-but-2-enedioic Acid;(e)-1-[4-(2-oxo-2-pyrrolidin-1-ylethyl)piperazin-1-yl]-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one
35. Cinepazide Maleate [who-dd]
36. Mfcd01320526
37. Nsc291562
38. S3045
39. Cinepazide Maleate, >=98% (hplc)
40. Akos015950975
41. Ccg-269931
42. 1-(4-((3',4',5'-trimethoxycinnamoyl)-1-piperazinyl)acetyl)pyrrolidine Maleate
43. 4-(3,4,5-trimethoxycinnamoyl)-1-(1-pyrrolidinyl)carbonylmethylpiperazine Maleate
44. As-17788
45. Hy-66010
46. Sw220164-1
47. Piperazine,4,5-trimethoxycinnamoyl)-, Maleate
48. D01944
49. 328c041
50. A818386
51. Q27294204
52. Piperazine,4,5-trimethoxyphenyl)-2-propenyl]-, (z)-2-butenedioate (1:1)
53. (z)-1-(4-((3',4',5'-trimethoxycinnamoyl)-1-piperazinyl)acetyl)pyrrolidinemaleate
54. Piperazine, 1-((1-pyrrolidinylcarbonyl)methyl)-4-(3',4',5'-trimethoxycinnamoyl)-, Maleate
55. (z)-but-2-enedioate; (e)-1-[4-(2-oxo-2-pyrrolidin-1-yl-ethyl)piperazin-1-yl]-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one;cinepazide Maleate
56. 1-(2-oxo-2-pyrrolidin-1-ylethyl)-4-(3-(3,4,5-trimethoxyphenyl)acryloyl)piperazine Monomaleate
57. 1-(4-(2-oxo-2-(pyrrolidin-1-yl)ethyl)piperazin-1-yl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one Maleate
58. 1202583-45-6
59. Piperazine, 1-(2-oxo-2-(1-pyrrolidinyl)ethyl)-4-(1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl)-, (z)-2-butenedioate (1:1)
| Molecular Weight | 533.6 g/mol |
|---|---|
| Molecular Formula | C26H35N3O9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 9 |
| Exact Mass | 533.23732970 g/mol |
| Monoisotopic Mass | 533.23732970 g/mol |
| Topological Polar Surface Area | 146 Ų |
| Heavy Atom Count | 38 |
| Formal Charge | 0 |
| Complexity | 705 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 2 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Cinepazide Maleate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cinepazide Maleate, including repackagers and relabelers. The FDA regulates Cinepazide Maleate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cinepazide Maleate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Cinepazide Maleate supplier is an individual or a company that provides Cinepazide Maleate active pharmaceutical ingredient (API) or Cinepazide Maleate finished formulations upon request. The Cinepazide Maleate suppliers may include Cinepazide Maleate API manufacturers, exporters, distributors and traders.
Cinepazide Maleate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cinepazide Maleate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cinepazide Maleate GMP manufacturer or Cinepazide Maleate GMP API supplier for your needs.
A Cinepazide Maleate CoA (Certificate of Analysis) is a formal document that attests to Cinepazide Maleate's compliance with Cinepazide Maleate specifications and serves as a tool for batch-level quality control.
Cinepazide Maleate CoA mostly includes findings from lab analyses of a specific batch. For each Cinepazide Maleate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cinepazide Maleate may be tested according to a variety of international standards, such as European Pharmacopoeia (Cinepazide Maleate EP), Cinepazide Maleate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cinepazide Maleate USP).
LOOKING FOR A SUPPLIER?
